Standout Papers
- ANTITHYMOCYTE SERUM AND METHOTREXATE FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS (1973)
- Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran. (1974)
- MARROW GRAFTS BETWEEN DL-A-MATCHED CANINE LITTERMATES (1973)
- Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs. (1979)
- RESCUE FROM CANINE GRAFT-VERSUS-HOST REACTION BY AUTOLOGOUS OR DL-A-COMPATIBLE MARRO,W (1974)
- EFFECT OF TIME ON SENSITIZATION TO HEMOPOIETIC GRAFTS BY PRECEDING BLOOD TRANSFUSION (1975)
Citation Impact
Citing Papers
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
2011
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party
2007
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Effective expansion of alloantigen-specific Foxp3 + CD25 + CD4 + regulatory T cells by dendritic cells during the mixed leukocyte reaction
2006 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
2013
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells
2005
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Severe Sepsis and Septic Shock
2013 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Immunotherapy to reconstitute immunity to DNA viruses
2002
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Clinical trials of antibody therapy
2000
Hematopoietic Stem-Cell Transplantation
2006 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy
2009
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Risk score for outcome after allogeneic hematopoietic stem cell transplantation
2009
Sarcoidosis
1997 Standout
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation
2004
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal Antibodies
1992
Endocrinological late complications after hematopoietic SCT in children
2008
Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats
1998
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
2003
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Epidemiology of lymphomas
2000
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle
1976
Experimental Infection of NOD/SCID Mice Reconstituted with Human CD34 + Cells with Epstein-Barr Virus
2004
Tissue Engineering
1993 StandoutScience
Acute Myeloid Leukemia
2015 Standout
Marrow Transplantation for Treatment of Aplastic Anemia
1977 StandoutNobel
ASSOCIATION BETWEEN HLA-B ANTIGENS AND ACUTE GRAFT-VERSUS-HOST DISEASE
1983
Serology and Genetics of the DL‐A System. I. Establishment of Specificities
1973 StandoutNobel
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
2005
Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? [see comments]
1994
Increased cancer risk in canine radiation chimeras
1980
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Bone-Marrow Transplantation
1975 StandoutNobel
MODELS FOR SYNGENEIC ADOPTIVE CHEMOIMMUNOTHERAPY OF MURINE LEUKEMIAS*
1976
Posthepatitic Severe Aplastic Anemia—An Indication for Early Bone Marrow Transplantation
1974
Bone-Marrow Transplantation
1975 Standout
Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors
1978
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patients
1980
CD4+ Tregs and immune control
2004 StandoutNobel
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Specific suppressor cells in graft–host tolerance of HLA-identical marrow transplantation
1981 StandoutNatureNobel
Allogeneic Marrow Grafting for Treatment of Aplastic Anemia
1974
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
Aplastic Anemia
1982 StandoutNobel
"Infectious" Transplantation Tolerance
1993 StandoutScience
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
Chimeric Antigen Receptor Therapy
2018 Standout
Lethal GVHD Across Minor Histocompatibility Barriers: Nature of the Effector Cells and Role of the H‐2 Complex
1983
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin
1979 StandoutNobel
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
Treatment of Established Human Graft-Versus-Host Disease by Antithymocyte Globulin
1974
Bone Marrow Transplantation in Severe Aplastic Anaemia: a Survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) *
1981
Post-Transplant Lymphoproliferative Disorders
2004
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Final adult height of patients who received hematopoietic cell transplantation in childhood
2004
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
1980 StandoutNobel
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
2002
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 Standout
Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice
2011 StandoutNobel
Marrow Transplantation for Treatment of Aplastic Anaemia
1978 StandoutNobel
Late Effects of Hematopoietic Cell Transplantation Among 10-Year Adult Survivors Compared With Case-Matched Controls
2005
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft- versus-host disease
1985
Stress Ulcer Prophylaxis in Critically III Patients
1996
HLA‐A,B and DR antigens in North Carolina Blacks with sarcoidosis
1983
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
2010
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Granulocyte Transfusions for the Prevention of Infection in Patients Receiving Bone-Marrow Transplants
1978 StandoutNobel
Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells
1979
Works of H. Kolb being referenced
Endothelial Cells but Not Epithelial Cells or Cardiomyocytes Are Partially Replaced by Donor Cells after Allogeneic Bone Marrow and Stem Cell Transplantation
2003
Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs.
1979 StandoutNobel
Antibody incubation of human marrow graft for prevention graft versus host disease
1980
Treatment of Established Graft-Versus-Host Disease in Dogs by Antithymocyte Serum or Prednisone
1973
Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group
1992
Dosisreduzierte Konditionierung vor allogener Stammzelltransplantation
2002
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction
2010
Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases
1988
ANTITHYMOCYTE SERUM AND METHOTREXATE FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS
1973 StandoutNobel
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.
1995
Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group
2008
In-vivo generation of leukaemia-derived dendritic cells
2004
THE EFFECT OF PRIOR BLOOD TRANSFUSIONS ON HEMOPOIETIC GRAFTS FROM HISTOINCOMPATIBLE CANINE LITTERMATES
1972
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.
1998
Late pulmonary impairment following allogeneic bone marrow transplantation.
1996
EFFECT OF TIME ON SENSITIZATION TO HEMOPOIETIC GRAFTS BY PRECEDING BLOOD TRANSFUSION
1975 StandoutNobel
Cyclosporine A Stimulates Endothelin Release
1995
THE EFFECT OF BUFFY COAT-POOR BLOOD TRANSFUSION ON SUBSEQUENT HEMOPOIETIC GRAFTS
1973
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
1999
Vergleich von Cimetidin-Pirenzepin und Antacida zur Streßblutungsprophylaxe bei Intensivpatienten: Eine kontrollierte klinische Studie an 120 Patienten
2008
Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects.
1992
MARROW GRAFTS BETWEEN DL-A-MATCHED CANINE LITTERMATES
1973 StandoutNobel
Identification of Four MLC‐Specificities in the Dog
1974
Immunobiology of Bone Marrow Transplantation
1980
Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran.
1974 StandoutNobel
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.
1999